Poster Download: antibody development and quality control by mass spectometry
Summary
evitria productions show consistent glycan profiles between batches. These profiles are in agreement with commercially available (GMP) antibodies.
Glycan analysis by LC-MS can verify glycan modifications, such as afucosylation, to provide further quality assurance.
The production of high quality, reproducible material is critical for the development of antibody-based therapeutics. The evitria-Genovis workflow combines rapid, high quality, antibody production with high-throughput mass spectrometry for greater insight and control of key quality attributes.
